This source reports that telogenic hair loss, while not leading to complete baldness, significantly impacts patients' quality of life due to its effects on their psychoemotional state; no standardized treatment currently exists, so therapy focuses on addressing trigger factors and psychological well-being.
April 2026 in “Global Journal of Health Science” This study observed that patients with hypothyroidism-associated hair loss commonly have deficiencies in several vitamins and minerals, suggesting that these deficiencies may be linked to their condition.
April 2026 in “International Journal of Ayurveda and Pharma Research” In this case report, a 42-year-old woman with hypothyroidism showed improvement in symptoms like fatigue and hair loss after following an Ayurvedic regimen including Kunjal Kriya, Yoga, and diet changes alongside her regular medication, though further clinical studies are recommended to validate these findings.
April 2026 in “Antibodies” This review discusses the uncertain role of immune factors, particularly autoantibodies, in the development of alopecia areata and emphasizes that identifying key autoantigens could lead to targeted immunotherapies.
This study found no significant differences in thyrotropin levels among patients with different types of nonscarring alopecia, though racial differences were observed in alopecia areata and telogen effluvium.
March 2026 in “Indian journal of veterinary and animal sciences research.” This case study found that treating a dog with primary hypothyroidism using oral levothyroxine sodium led to significant clinical improvement within six weeks.
February 2026 in “Editora Pasteur eBooks” An integrative approach combining medical, nutritional, and lifestyle changes effectively manages female pattern hair loss.
February 2026 in “Editora Pasteur eBooks” This abstract does not report specific research results but introduces a book focusing on the intersection of endocrinology and aesthetic medicine and its growing importance in contemporary clinical practice.
February 2026 in “International Journal of Homoeopathic Sciences” This report describes a case of severe hair loss with accompanying thyroid issues and eczema that improved noticeably after individualized homeopathic treatment, following unsuccessful previous methods, as observed at Dr Batra’s® Homeopathy Clinic.
January 2026 in “Scholars Journal of Medical Case Reports” This article outlines a diagnostic and treatment approach for polycystic ovarian syndrome in young women, emphasizing lifestyle modifications, hormonal treatments, and specialist referrals for managing symptoms and fertility concerns.
January 2026 in “The Pharma Innovation” This article discusses hypothyroidism, its symptoms, causes, and the importance of lifestyle modifications in supporting thyroid health, but it reports no new clinical results.
January 2026 in “Journal of Case Reports and Scientific Images” This paper highlights the potential efficacy of constitutional homeopathic medicine, supplemented with dietary guidance and management of associated diseases like thyroid disorders, in treating alopecia areata to expedite recovery and reduce recurrence.
January 2026 in “International Journal of Advanced Biochemistry Research” This case report describes a 4-year-old dog successfully managed for primary hypothyroidism and concurrent Babesia gibsoni infection, treated with thyroxine, Diminazine aceturate, antibiotics, and supportive therapies, resulting in clinical improvement and negative blood smear for Babesia by day 30.
January 2026 in “Dermatologic Therapy” This review discusses female pattern hair loss as an early marker of hormonal imbalance and evaluates hormonal and lifestyle interventions, but reports no new clinical results.
December 2025 in “Journal of Integrated Standardized Homoeopathy” This case report describes the use of individualized homoeopathic treatment and dietary modifications to manage hypothyroidism in a 23-year-old woman, resulting in symptom improvement and normalized TSH levels after tapering off levothyroxine.
December 2025 in “Archives of Current Research International” This study conducted in Hyderabad found an incidence of 1.02% congenital goitre in goats, primarily due to iodine deficiency causing hypothyroidism, and observed significant clinical and hormonal improvement in 88.89% of cases treated with levothyroxine and potassium iodide.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study discusses various causes and treatments of hair loss, with a focus on the potential effectiveness of Ayurvedic and synthetic methods, but emphasizes that more research is needed for specific conditions like Telogen Effluvium.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this review, various causes of hair loss, such as nutritional deficiencies and stress, are discussed alongside potential treatments including Ayurvedic formulations and synthetic options like minoxidil, while emphasizing the need for further studies on conditions like Telogen Effluvium and Female Pattern Hair Loss.
November 2025 in “International Journal of Innovative Research in Technology” This study assesses the impact of teaching programs on the knowledge of waste management among women, but results are not reported in the abstract.
October 2025 in “World Journal of Biology Pharmacy and Health Sciences” This review highlights the role of sex hormones in skin health, observing that hormonal changes throughout a woman's life can affect skin conditions such as acne and hair loss, with treatments involving hormonal therapies and the importance of a multidisciplinary approach.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study outlines that for addressing hair loss in young women, a comprehensive approach including hormonal evaluation, thyroid function, iron and vitamin D testing, along with clinical assessments like pull tests and trichoscopy, is recommended.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study recommends a combination of hormonal and thyroid evaluations, iron studies, vitamin D testing, and clinical assessments like pull tests and trichoscopy for investigating hair loss in young women.
October 2025 in “Journal of the Endocrine Society” This case report describes a 36-year-old female patient with panhypopituitarism, experiencing severe adrenal insufficiency and thyroid hormone deficiency, which led to electrolyte imbalance, QT interval prolongation, and ventricular tachycardia; treatment stabilized her condition, underscoring the importance of hormonal evaluation in arrhythmia assessment.
September 2025 in “International Journal of Zoology and Applied Biosciences” This study found that women aged 21-26 with PCOS showed significant differences in biochemical and hormonal profiles, such as blood sugar and hormone levels, compared to healthy individuals, suggesting an increased incidence of PCOS in this age group.
August 2025 in “Dermatology and Therapy” This study found that among US adults with vitiligo, the most prevalent autoimmune comorbidities were thyroid disease and alopecia areata, with evidence suggesting greater vitiligo extent increases prevalence of several autoimmune conditions.
July 2025 in “Foundation University Journal of Dentistry” In this study, 25% of alopecia areata patients were found to have autoimmune disorders, with hypothyroidism being the most common, highlighting the importance of screening for autoimmune conditions, particularly thyroid disorders, in these patients.
July 2025 in “Russian Journal of Skin and Venereal Diseases” This article discusses the characteristics, diagnosis, and clinical presentation of different variants of lichen planopilaris on the scalp, with emphasis on cicatricial alopecia and the importance of clinical and trichoscopic monitoring; it presents no new clinical results.
In this study, researchers explored the diverse causes of alopecia in dogs, highlighting how factors such as infection, hormonal imbalances, and genetic conditions contribute to hair loss, and emphasized the importance of tailored diagnostics and treatment strategies.
July 2025 in “The Journal of Dermatology” This study identified common and unexpected adverse events associated with ritlecitinib in real-world use, providing insights into its safety profile for treating severe alopecia areata.
July 2025 in “Indus journal of bioscience research.” This study found that women with polycystic ovary syndrome showed significant differences in clinical symptoms, hormone levels, and ovarian morphology compared to healthy controls, such as higher body mass index, menstrual irregularities, elevated luteinizing hormone, and polycystic ovarian morphology, suggesting these factors enhance diagnostic accuracy.